Webinar: A disease state approach to the pharmacological management of type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe

Webinar recorded on October 7, 2020

Understanding the rationale for avoiding therapeutic inertia and the use of early combination therapy.
Identifying simplified risk categories of type 2 diabetes in the primary care setting. What really matters?
Treatment recommendations

	Chairman Manel Mata-Cases Researcher of the Barcelona Ciutat Research Support Unit of the Primary Healthcare Research Institute Jordi Gol (IDIAP-Jordi Gol, Barcelona, Spain)
Speakers
	Francesc Xavier Cos Claramunt PCDE chairman Associate Professor in General Practice. Universitat Autònoma de Barcelona. Why early combination therapy in type 2 diabetes?
	Samuel Seidu MBChB, PGCME, MSc, MD, FRCGP, FRCP (Edin) NIHR Clinical Lecturer in Primary Care. Diabetes Research Centre, University of Leicester. Simplified risk categories in type 2 diabetes from the primary care perspective.
	Stefan Jansson Scientist at University Health Care Research Center, School of Health and Medical Sciences, Örebro University, Sweden. General practitioner at Brickebacken Health Care Center, Örebro Sweden. Consensus recommendations

Manel Mata-Cases